A single-center, retrospective study-spring-evaluating the efficacy and safety of recombinant human vascular endothelial inhibitor combined with anti-PD-1 in elderly patients aged 80 and above with…

Overview of attention for article published in Frontiers in immunology, June 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (58th percentile)

So far, Altmetric has seen 2 Reddit threads by 2 users.

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.